Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L4 pseudogene 2 (RPL4P2)
- Target
- RPL4P2
- Molecular classification
- Other (processed pseudogene)
01
Overview
Ribosomal protein L4 pseudogene 2 (RPL4P2) is a human processed pseudogene, related in sequence to the ribosomal protein L4 gene (RPL4), but does not code for a functional protein product. Pseudogenes such as RPL4P2 arise through duplication or retrotransposition events and are generally transcriptionally silent, though some can have regulatory effects as non-coding RNAs. RPL4P2 has no known coding potential, does not participate in ribosome assembly, and is not considered a therapeutic drug target. There is currently no evidence for RPL4P2 having direct roles in disease, drug interaction, or being used as a biomarker. Important note: The functional ribosomal protein L4 (RPL4) is different—it is a protein-coding gene and is part of the large ribosomal subunit essential for protein synthesis. RPL4P2 is only a noncoding pseudogene related to the RPL4 family, and not a receptor, enzyme, or transporter.
- Other names
- RPL4_1_115
02
Mechanism of action
None (no evidence for drug targeting or functional protein product)
03
Biological functions
Other (no known direct protein function; if transcribed, potential non-coding RNA roles are possible but are not established for RPL4P2)
04
Disease associations
Other (pseudogenes from ribosomal protein genes are associated generally with genomic processes and sometimes implicated in gene regulation or disease as non-coding RNAs, but no direct evidence for a role for RPL4P2 itself)
05
Safety considerations
None known (not a drug target, so no safety profile exists)
06
Interacting drugs
None known
07
Biomarkers
None directly. (Ribosomal protein pseudogenes as a class may be used in biomarker discovery, but RPL4P2 is not itself an established biomarker or disease indicator)
Beyond the preview
Go deeper on Ribosomal protein L4 pseudogene 2 (RPL4P2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L4 pseudogene 2 (RPL4P2).